Global Weight Loss & Diabetes Medicines Portfolio
Market Opportunity GLP-1 receptor agonists and dual agonists (semaglutide & tirzepatide) are among the fastest-growing pharmaceutical segments globally, with sales in tens of billions of USD. In India, demand is surging due to rising diabetes and obesity rates. The market offers excellent opportunities with a mix of originator brands (via local partnerships) and high-volume, affordable Indian generics/biosimilars.
1. Tirzepatide (Dual GIP + GLP-1 Agonist)
Currently one of the top-selling weight loss & diabetes drugs worldwide
Mounjaro – Product Overview Manufacturer: Eli Lilly (India partnership with Cipla) Active Ingredient: Tirzepatide Dosage Form: Once-weekly subcutaneous injection Indications: Type 2 Diabetes Mellitus & chronic weight management (adults with obesity or overweight with comorbidities) India Launch: March 2025 (vials) | KwikPen introduced later in 2025 Status: Rx Only | Exceptional demand and repeat prescriptions
Available Dosage Strengths
| Strength | Pack Type | Doses per Pack | Recommended Use |
|---|---|---|---|
| 2.5 mg | Single-dose Vial | 1 dose | Starter dose |
| 5 mg | Single-dose Vial / KwikPen | 1 or 4 doses | Initial maintenance dose |
| 7.5 mg | KwikPen | 4 doses | Dose escalation |
| 10 mg | KwikPen | 4 doses | Standard effective dose |
| 12.5 mg | KwikPen | 4 doses | Higher therapeutic dose |
| 15 mg | KwikPen | 4 doses | Maximum approved dose |
Key Trade Advantages
- Highly patient-friendly KwikPen (pre-filled, multi-dose) for better compliance
- Strong clinical outcomes in both glycemic control and significant weight reduction
- Genuine Eli Lilly India packaging with security features and full regulatory compliance
- Cold chain product with good shelf life
Storage: Refrigerate at 2–8°C. Stable at room temperature (<30°C) for up to 30 days. Long expiry.
2. Semaglutide (GLP-1 Receptor Agonist)
Highest volume & most established molecule in the category
Branded Options Ozempic (Novo Nordisk)
- Indications: Primarily Type 2 Diabetes (with significant weight loss benefits)
- Strengths: 0.25 mg, 0.5 mg, 1.0 mg (weekly pens)
- Pack: Pre-filled pens
- Widely available and doctor-preferred for diabetes management
Wegovy / Poviztra (Novo Nordisk with Emcure)
- Indications: Chronic weight management (higher dose focus)
- Strengths: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg (weekly)
- Pack: Pre-filled pens (typically 4 doses)
- Strong brand pull in weight management clinics
Indian Generic / Biosimilar Versions (Post-patent – High Volume Opportunity) Over 40 Indian manufacturers have launched versions, offering 50-70% lower cost than originators. Excellent margins and fast turnover.
Leading Manufacturers & Brands:
- Sun Pharmaceutical Industries
- Noveltreat (weight loss focus) & Sematrinity (diabetes + weight loss)
- Injectable pens (0.25 mg to 2.4 mg) + oral tablet options
- Dr. Reddy’s Laboratories
- Obeda – 2 mg & 4 mg prefilled disposable pens
- Zydus Lifesciences
- Semaglyn, Mashema, Alterme – 15 mg/3 mL multi-dose cartridge pens
- Other Prominent Players: Alkem (Semasize, Obesema), Natco, Torrent, Glenmark, Eris, Lupin, Mankind, etc.
Common Formats: Weekly pre-filled pens (0.25 mg to 2.4 mg titration) + Oral tablets (Rybelsus-like)
Key Trade Advantages
- Proven track record and high doctor confidence
- Multiple price points for different customer segments (Ozempic for diabetes, Wegovy for obesity, generics for volume)
- High repeat purchase rate
Storage: Refrigerate at 2–8°C. Follow specific pack instructions for room temperature use.
3. Liraglutide (GLP-1 Agonist) – Daily Injectable
Reliable & Affordable Alternative
Key Brand: Lirafit (Glenmark) + Biocon biosimilar
- Strengths: 0.6 mg, 1.2 mg, 1.8 mg up to 3.0 mg daily
- Pack: Multi-dose pre-filled pens (3 mL)
- Indications: Type 2 Diabetes & weight management
- Significantly cheaper than newer weekly injectables
Why Source from Ametheus Holdings?
- Curated portfolio covering branded (Mounjaro, Ozempic, Wegovy) and generic options
- 100% genuine products with complete documentation (Certificates of Analysis, Import/Manufacturing licenses, GST compliance)
- Competitive wholesale pricing with flexible MOQ
- Reliable pan-India cold chain logistics and timely delivery
- Marketing support materials (product sheets, images, doctor communication aids)
We help you build a complete Anti-Obesity & Diabetes Injectable range for maximum profitability.
Next Steps – Contact us today for:
- Detailed price list & MOQ
- High-resolution product images & catalogues
- Side-by-side comparison charts
- Customized buyer presentations
Contact: Ametheus Holdings Pvt Ltd | Phone: +91-9999999538, +91-9999099538, +91-9999156157
Email: info(at)ametheus(dot)com [ [email protected] ]
